Reliance Life Sciences Gets CDSCO Panel Nod for Phase I/III Trial of Biosimilar Nivolumab
- 14 October 2025
- 2 weeks ago
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRel
- 22 September 2025
- 1 month ago
USFDA concludes audit at Cohance Lifesciences Jaggaiahpet facility
- 13 September 2025
- 1 month ago
Recent News
Himachal notifies Resident doctor policy 2025
- 02 November, 2025
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.



